Extensive lymph node metastases found by 18F-FDG-PET/CT in a patient with diffuse sclerosing variant of papillary thyroid carcinoma

Hellenic Journal of Nuclear Medicine

Volumn 14, Issue 2, 2011, Pages

  Xu, Yan Hong ^a,b   Song, Hong Jun ^b   Qiu, Zhong Ling ^b   Luo, Quan Yong ^b  

^a SOOCHOW UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3700MBQ; FLUORODEOXYGLUCOSE F 18; IODINE 131; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LETTER; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; THYROID CARCINOMA; THYROIDECTOMY;

ADULT; AUTOANTIBODIES; FLUORODEOXYGLUCOSE F18; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THYROGLOBULIN; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 79961161149     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Letter

References (15)

1. Vickery AL, Carcangiu ML, Johannessen JV et al. Papillary carcinoma. Semin Diagn Pathol 1985; 2: 90-100.
2. Sywak M, Pasieka J, Ogilvie T. A review of thyroid cancer with intermediate differentiation. J Surg Oncol 2004; 86: 44-54. (Pubitemid 38490100)
3. Fujimoto Y, Obara T, Ito Y et al. Diffuse sclerosing variant of papillary carcinoma of the thyroid. Clinical importance, surgical treatment, and follow-up study. Cancer 1990; 66: 2306-12.
4. Soares J, Limbert E, Sobrinho-Simoes M. Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases. Pathol Res Pract 1989; 2: 200-6.
5. Papadopoulou F, Efthimiou E. Thyroid cancer after external or internal ionizing irradiation. Hell J Nucl Med 2009; 12: 266-70.
6. Chow SM, Chan JK, Law SC et al. Diffuse sclerosing variant of papillary thyroid carcinoma-clinical features and outcome. Eur J Surg Oncol 2003; 29: 446-9. (Pubitemid 36748588)
7. Imamura Y, Kasahara Y, Fukuda M. Multiple brain metastases from a diffuse sclerosing variant of papillary carcinoma of the thyroid. Endocr Pathol 2000; 11: 97-108. (Pubitemid 30307949)
8. Duntas L, Grab-Duntas BM. Risk and prognostic factors for differentiated thyroid cancer. Hell J Nucl Med 2006; 9: 156-62. (Pubitemid 46138761)
9. Lam AK, Lo CY. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Ann Surg Oncol 2006; 13: 176-81. (Pubitemid 43157411)
10. Chung JK, Park YJ, Kim TY et al. Clinical significance of elevated level of serum anti-thyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocr 2002; 57: 215-21. (Pubitemid 34989098)
11. Misra M, Parangi S, Ross DS et al. Case 38-2010: a 13-year-old girl with an enlarging neck mass. N Engl J Med 2010; 363: 2445-54.
12. 18F-FDG-PET imaging in a patient with diffuse sclerosing variant of papillary thyroid cancer. Clin Nucl Med 2008; 33: 834-7.
13. 18F-FDG PET/CT. Clin Endocrinol 2010; 4: 558-63.
14. Carting T, Ocal IT, Udelsman R. Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer? World J Surg 2007; 31: 916-23. (Pubitemid 46716778)
15. Kepenekci I, Demirkan A, Cakmak A et al. Axillary lymph node metastasis as a late manifestation of papillary thyroid carcinoma. Thyroid 2009; 19: 417-9.